EUVIMEDEUVIMED entdecken
Crossref

Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients

Hideki Ijichi, Wakako Tajiri, Yumiko Koi, Chinami Koga, Yoshiaki Nakamura, Masahiro Okamoto, Eriko Tokunaga

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2023.11.075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Hideki Ijichi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Electronic address: h_iditi@yahoo.co.jp. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Neutrophil-to-lymphocyte ratio (NLR) has been recognized as a marker of systemic inflammation with a prognostic impact in patients with various cancers, including breast cancer. The aim of this study was to investigate the relationships between the preoperative NLR and breast cancer prognosis in the patients before and after menopausal age, and its relationship with other prognostic factors. METHODS: A total of 1868 patients with clinical Stage I-III primary breast cancer were enrolled. The associations between clinicopathological factors and the preoperative NLR were analyzed, and relapse-free survival (RFS) and overall survival (OS) were estimated. RESULTS: Statistical analyses stratified by the menopausal status revealed that a high NLR was significantly associated with worse RFS (P < 0.001) and OS (P = 0.001) in postmenopausal patients, but not in premenopausal patients. Although the postmenopausal patients with relapsed cancer tended to have higher NLR levels than those without relapse (P = 0.079), NLR levels of premenopausal patients with relapsed cancer were significantly lower than that of relapse-free patients (P = 0.024). In postmenopausal patients, a high NLR was only associated with worse RFS in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (P < 0.001), in those managed without adjuvant chemotherapy (P = 0.003); this association was not observed in patients who received adjuvant chemotherapy. CONCLUSIONS: The preoperative NLR can be a useful prognostic marker, especially in postmenopausal breast cancer patients. The relationships between the NLR and breast cancer prognosis may be more evident when patients are assessed according to their menopausal status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleNeutrophilsLymphocyte CountPostmenopauseDisease-Free SurvivalNeoplasm Recurrence, LocalLymphocytesPrognosisRetrospective Studies

Stichwörter der Autor:innen

Breast cancerMenopausal statusNeutrophil-to-lymphocyte ratioPostmenopausal breast cancer patientPrognostic marker

Autor:innen und Institutionen

  • Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Electronic address: h_iditi@yahoo.co.jp.
  • Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

Zitieren

APA

Ijichi, H., Tajiri, W., Koi, Y., Koga, C., Nakamura, Y., Okamoto, M., & Tokunaga, E. (2024). Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.11.075

Vancouver

Ijichi H, Tajiri W, Koi Y, Koga C, Nakamura Y, Okamoto M, et al. Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2023.11.075

BibTeX
@article{Ijichi2024,
  author = {Ijichi, Hideki and Tajiri, Wakako and Koi, Yumiko and Koga, Chinami and Nakamura, Yoshiaki and Okamoto, Masahiro and Tokunaga, Eriko},
  title = {Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2023.11.075}
}
Kostenlos starten →